Literature DB >> 25205448

Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.

Pedro W Rosario1, Gabriela F Mourão, Thassio L Siman, Maria R Calsolari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25205448     DOI： 10.1007/s12020-014-0414-8

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  13 in total

1.  Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy.

Authors:  Dae-Weung Kim; Se Jeong Jeon; Chang Guhn Kim
Journal:  Endocrine       Date:  2012-02-18       Impact factor: 3.633

2.  Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.

Authors:  Osama Al-Saif; William B Farrar; Mark Bloomston; Kyle Porter; Matthew D Ringel; Richard T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2010-03-23       Impact factor: 5.958

3.  Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma.

Authors:  Pedro Weslley Souza Rosário; Sérgio de Faria; Luciano Bicalho; Maria Flávia Gatti Alves; Michelle Aparecida Ribeiro Borges; Saulo Purisch; Eduardo Lanza Padrão; Leonardo Lamego Rezende; Alvaro Luís Barroso
Journal:  J Ultrasound Med       Date:  2005-10       Impact factor: 2.153

4.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

Authors:  Dominique Delbeke; R Edward Coleman; Milton J Guiberteau; Manuel L Brown; Henry D Royal; Barry A Siegel; David W Townsend; Lincoln L Berland; J Anthony Parker; Karl Hubner; Michael G Stabin; George Zubal; Marc Kachelriess; Valerie Cronin; Scott Holbrook
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

5.  Ultrasound-guided percutaneous ethanol injection in papillary thyroid cancer metastatic lymph-nodes.

Authors:  Guia Vannucchi; Danila Covelli; Michela Perrino; Simone De Leo; Laura Fugazzola
Journal:  Endocrine       Date:  2014-03-08       Impact factor: 3.633

6.  Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation.

Authors:  Ji Hye Yim; Won Bae Kim; Eui Young Kim; Won Gu Kim; Tae Yong Kim; Jin-Sook Ryu; Dae Hyuk Moon; Tae-Yon Sung; Jong Ho Yoon; Seong Chul Kim; Suck Joon Hong; Young Kee Shong
Journal:  J Clin Endocrinol Metab       Date:  2011-10-05       Impact factor: 5.958

7.  Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative.

Authors:  Mark L Urken; Mira Milas; Gregory W Randolph; Ralph Tufano; Donald Bergman; Victor Bernet; Elise M Brett; James D Brierley; Rhoda Cobin; Gerard Doherty; Joshua Klopper; Stephanie Lee; Josef Machac; Jeffrey I Mechanick; Lisa A Orloff; Douglas Ross; Robert C Smallridge; David J Terris; Jason B Clain; Michael Tuttle
Journal:  Head Neck       Date:  2014-04-03       Impact factor: 3.147

8.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

9.  Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?

Authors:  Pedro Weslley Rosario; Gabriela Franco Mourão; Juan Bernard Nascimento dos Santos; Maria Regina Calsolari
Journal:  Thyroid       Date:  2013-12-10       Impact factor: 6.568

10.  Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.

Authors:  Sophie Leboulleux; Intidhar El Bez; Isabelle Borget; Manel Elleuch; Désirée Déandreis; Abir Al Ghuzlan; Cécile Chougnet; François Bidault; Haitham Mirghani; Jean Lumbroso; Dana Hartl; Eric Baudin; Martin Schlumberger
Journal:  Thyroid       Date:  2012-08       Impact factor: 6.568
View more
  2 in total

1.  Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.

Authors:  F Guidoccio; M Grosso; A Antonelli
Journal:  Endocrine       Date:  2014-12-06       Impact factor: 3.633

2.  Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer.

Authors:  Matthew L Hung; James X Wu; Ning Li; Masha J Livhits; Michael W Yeh
Journal:  JAMA Surg       Date:  2018-12-01       Impact factor: 14.766
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.